Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Quarterly results
CC transcript
|
|
INCYTE CORP (INCY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Denton Sheila A. (EVP & General Counsel) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 26,524 shares
@ $0
Granted 28,725 options to buy
@ $58.06, valued at
$1.7M
|
|
| 10/04/2023 |
3
| Denton Sheila A. (EVP & General Counsel) has filed a Form 3 on INCYTE CORP |
| 10/03/2023 |
4
| BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 510 shares
@ $0 |
|
| 10/03/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 389 shares
@ $57.77, valued at
$22.5k
|
|
| 10/03/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 379 shares
@ $57.77, valued at
$21.9k
|
|
| 08/14/2023 |
SC 13D/A
| INCYTE CORP reports a 6.9% stake in Merus n.v. |
| 08/03/2023 |
4
| Stein Steven H (EVP & Chief Medical Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 21,511 shares
@ $63.28, valued at
$1.4M
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| CAGNONI PABLO J (President, R&D) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 9,668 shares
@ $0
Granted 20,275 options to buy
@ $61.76, valued at
$1.3M
|
|
| 07/18/2023 |
4
| Hoppenot Herve (Chairman / CEO) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 43,184 shares
@ $0
Granted 90,563 options to buy
@ $61.76, valued at
$5.6M
|
|
| 07/18/2023 |
4
| Stein Steven H (EVP & Chief Medical Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 13,535 shares
@ $0
Granted 28,385 options to buy
@ $61.76, valued at
$1.8M
|
|
| 07/18/2023 |
4
| Flannelly Barry P (EVP & General Manager US) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 9,668 shares
@ $0
Granted 20,275 options to buy
@ $61.76, valued at
$1.3M
|
|
| 07/06/2023 |
4
| Hoppenot Herve (Chairman / CEO) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 43,467 shares
@ $62.08, valued at
$2.7M
|
|
| 07/06/2023 |
4
| Flannelly Barry P (EVP & General Manager US) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 6,304 shares
@ $62.08, valued at
$391.4k
|
|
| 07/06/2023 |
4
| SWAIN PAULA J (EVP, Human Resources) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 5,783 shares
@ $62.08, valued at
$359k
|
|
| 07/06/2023 |
4
| Tray Thomas (Principal Accounting Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 1,136 shares
@ $62.08, valued at
$70.5k
|
|
| 07/06/2023 |
4
| Stamoulis Christiana (EVP & CFO) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 6,073 shares
@ $62.08, valued at
$377k
|
|
| 07/06/2023 |
4
| Pasquale Maria E (EVP & General Counsel) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 8,468 shares
@ $62.08, valued at
$525.7k
|
|
| 07/06/2023 |
4
| Stein Steven H (EVP & Chief Medical Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 8,442 shares
@ $62.08, valued at
$524.1k
|
|
| 07/06/2023 |
4
| Iyengar Vijay K (EVP, GMAPPS) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 6,215 shares
@ $62.08, valued at
$385.8k
|
|
| 07/06/2023 |
4
| Dhanak Dashyant (EVP & Chief Scientific Officer) has filed a Form 4 on INCYTE CORP|
Txns:
| Paid exercise price by delivering 6,044 shares
@ $62.08, valued at
$375.2k
|
|
| 07/05/2023 |
4
| BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 512 shares
@ $0 |
|
| 07/05/2023 |
4
| HARRIGAN EDMUND (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 390 shares
@ $62.25, valued at
$24.3k
|
|
| 07/05/2023 |
4
| Clancy Paul J (Director) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 380 shares
@ $62.25, valued at
$23.7k
|
|
| 06/30/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/30/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|
|
|